Abstract
Terpenoids and especially triterpenoids are the largest and the most diverse group of naturally occurring organic compounds. Its diversity plays very important role in new chemical entities activity screening against different disorders. Some of these compounds and their semi-synthetic derivatives can be identified as potential therapeutics against neurodegenerative diseases and were widely studied in the last few years. Celastrol, oleanolic acid, ursolic acid, asiatic acid, erythrodiol, and some triterpenoid saponins have the ability to protect the brain against neurodegenerative and neuroinflammatory processes. This review article is focused on triterpenoids as possible drugs to treat or slow the progression of neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer’s Disease (AD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS).
Keywords: Triterpenoids, neurodegeneration, celastrol, neuroinflammation, natural terpenoids, pharmacology, dementia, animal models, HIV-encephalopathy.
Mini-Reviews in Organic Chemistry
Title:Natural Triterpenoids and their Derivatives with Pharmacological Activity Against Neurodegenerative Disorders
Volume: 11 Issue: 3
Author(s): Piotr Ruszkowski and Teresa Bobkiewicz-Kozlowska
Affiliation:
Keywords: Triterpenoids, neurodegeneration, celastrol, neuroinflammation, natural terpenoids, pharmacology, dementia, animal models, HIV-encephalopathy.
Abstract: Terpenoids and especially triterpenoids are the largest and the most diverse group of naturally occurring organic compounds. Its diversity plays very important role in new chemical entities activity screening against different disorders. Some of these compounds and their semi-synthetic derivatives can be identified as potential therapeutics against neurodegenerative diseases and were widely studied in the last few years. Celastrol, oleanolic acid, ursolic acid, asiatic acid, erythrodiol, and some triterpenoid saponins have the ability to protect the brain against neurodegenerative and neuroinflammatory processes. This review article is focused on triterpenoids as possible drugs to treat or slow the progression of neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer’s Disease (AD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS).
Export Options
About this article
Cite this article as:
Ruszkowski Piotr and Bobkiewicz-Kozlowska Teresa, Natural Triterpenoids and their Derivatives with Pharmacological Activity Against Neurodegenerative Disorders, Mini-Reviews in Organic Chemistry 2014; 11 (3) . https://dx.doi.org/10.2174/1570193X1103140915111559
DOI https://dx.doi.org/10.2174/1570193X1103140915111559 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Applications of Molecular Descriptors in Physicochemical Properties Research of Organic Compounds
Chemical graph theory is concerned with all aspects of the application of graph theory to various areas of chemistry, including organic, theoretical, mathematical, and computational chemistry, as well as in bioinformatics and computational biology. By the use of the term chemical it is emphasized that one is allowed in chemical ...read more
Exploring New Frontiers in Anti-inflammatory Treatment with Small Molecule Compounds
This thematic issue is dedicated to the latest advancements and research breakthroughs in the realm of anti-inflammatory pharmacotherapy. With inflammation playing a critical role in numerous chronic conditions such as cardiovascular diseases, diabetes, and autoimmune disorders, there is an urgent need for more targeted, effective, and safer anti-inflammatory treatments. This ...read more
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treating Cancer in Older and Oldest Old Patients
Current Pharmaceutical Design Fontan Circulation Might be Associated with Peripartum Cardiomyopathy: A Review of Mechanistic and Clinical Aspects
Current Cardiology Reviews Potential Roles of MyomiRs in Cardiac Development and Related Diseases
Current Cardiology Reviews Calcium Channel Blockers in Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Current Neuropharmacology Current State of Development of Genome Analysis in Livestock
Current Genomics In Vivo Imaging of Apoptosis in Cancer: Potentials and Drawbacks of Molecular Probes
Current Molecular Imaging (Discontinued) Refractory Angina Pectoris: Lessons from the Past and Current Perspectives
Current Pharmaceutical Design Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice
Current Cardiology Reviews Pharmacotherapy of Dilated Cardiomyopathy
Current Pharmaceutical Design Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews Editorial [ Hot Topic: Modifying Cardiovascular Risk Factors: Novel Cardiovascular Targets for Treatment by Noninvasive Imaging Techniques (Executive Editors: Aurelio Leone and Luigi Landini) ]
Current Pharmaceutical Design Genetics and Heart Failure: A Concise Guide for the Clinician
Current Cardiology Reviews ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Cardiac Imaging in Heart Failure with Comorbidities
Current Cardiology Reviews Autoimmunity and Celiac Disease
Mini-Reviews in Medicinal Chemistry Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment
Current Pharmaceutical Biotechnology The Evolving Roles of Nuclear Cardiology
Current Cardiology Reviews Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Current Pharmaceutical Design